X

Rezolve Ai CEO On Commerce Transformation

Daniel Wagner, CEO of Rezolve Ai, discusses how artificial intelligence is transforming commerce experiences. On AI Applications Q: How is…

OS Therapies CEO On Osteosarcoma Treatment

Paul Romness, CEO of OS Therapies, discusses the company's commitment to developing treatments for osteosarcoma. On Unmet Need Q: Why…

Richtech Robotics CEO On Service Robots

Zheng Zhong, CEO of Richtech Robotics, discusses the growing adoption of service robots across industries. On Market Trends Q: What…

Intensity Therapeutics CEO On Intratumoral Approach

Lewis Bender, CEO of Intensity Therapeutics, discusses the company's intratumoral drug delivery approach. On Technology Platform Q: Can you explain…

Profusa CEO On Health Monitoring

Dr. Ben Hwang, CEO of Profusa, discusses the future of continuous health monitoring through implantable biosensors. On Technology Vision Q:…

Envoy Medical CEO On Hearing Health

Brent Lucas, CEO of Envoy Medical, discusses innovations in hearing health technology. On Market Need Q: Why is hearing health…

Procter & Gamble set to report Q2 earnings next week. Here’s what to expect

Procter & Gamble Company (NYSE: PG) is gearing up for its latest earnings report while navigating a challenging market environment…

McCormick (MKC) expected to report higher revenue and earnings in Q4 2025

Shares of McCormick & Company, Incorporated (NYSE: MKC) stayed green on Wednesday. The stock has gained 4% in the past…

Key metrics from Citigroup’s (C) Q4 2025 earnings results

Citigroup Inc. (NYSE: C) reported its fourth quarter 2025 earnings results today. Revenues increased 2% year-over-year to $19.9 billion, driven…

Bank of America reports higher Q4 revenue and profit; results beat estimates

Bank of America Corporation (NYSE: BAC) on Wednesday announced financial results for the fourth quarter of fiscal 2025, with strong…